Published in Biomaterials on October 30, 2007
Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev (2008) 1.52
Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. J Control Release (2014) 1.44
Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res (2009) 1.43
Advances in molecular imaging with ultrasound. Mol Imaging (2010) 1.42
Microbubble Compositions, Properties and Biomedical Applications. Bubble Sci Eng Technol (2009) 1.29
Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 1.18
Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics (2012) 1.15
The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces. Biomaterials (2011) 0.98
Whole animal imaging. Wiley Interdiscip Rev Syst Biol Med (2010) 0.94
Phase-shift, stimuli-responsive drug carriers for targeted delivery. Ther Deliv (2011) 0.90
Action at a distance: lengthening adhesion bonds with poly(ethylene glycol) spacers enhances mechanically stressed affinity for improved vascular targeting of microparticles. Langmuir (2009) 0.89
Ligand conjugation to bimodal poly(ethylene glycol) brush layers on microbubbles. Langmuir (2010) 0.89
Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles. Ultrasound Med Biol (2012) 0.88
The effect of lipid monolayer in-plane rigidity on in vivo microbubble circulation persistence. Biomaterials (2013) 0.88
Targeted drug delivery across the blood-brain barrier using ultrasound technique. Ther Deliv (2010) 0.87
Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice. ACS Nano (2015) 0.87
Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble. Biomaterials (2015) 0.83
The pharmacology of regenerative medicine. Pharmacol Rev (2013) 0.83
The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium. J Control Release (2012) 0.83
Creating brain lesions with low-intensity focused ultrasound with microbubbles: a rat study at half a megahertz. Ultrasound Med Biol (2013) 0.83
Engineering optically triggered droplets for photoacoustic imaging and therapy. Biomed Opt Express (2014) 0.83
Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies. Ultrasound Med Biol (2012) 0.82
In vivo ultrasound visualization of non-occlusive blood clots with thrombin-sensitive contrast agents. Biomaterials (2013) 0.82
In vivo demonstration of cancer molecular imaging with ultrasound radiation force and buried-ligand microbubbles. Mol Imaging (2013) 0.80
Factors affecting the endothelial retention of targeted microbubbles: influence of microbubble shell design and cell surface projection of the endothelial target molecule. J Am Soc Echocardiogr (2012) 0.79
Microbubbles as biocompatible porogens for hydrogel scaffolds. Acta Biomater (2012) 0.78
Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics. Theranostics (2015) 0.76
Fabrication of thermo-sensitive complex micelles for reversible cell targeting. J Mater Sci Mater Med (2015) 0.75
Targeted binding of PEG-lipid modified polymer ultrasound contrast agents with tiered surface architecture. Biotechnol Bioeng (2010) 0.75
Magnetically-coated silica nanospheres for dual-mode imaging at low ultrasound frequency. World J Radiol (2013) 0.75
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng (2007) 5.82
Structures of complement component C3 provide insights into the function and evolution of immunity. Nature (2005) 4.01
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation (2003) 3.15
Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov (2004) 3.09
Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation (2001) 2.70
Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev (2001) 2.69
Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation (2003) 2.67
Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys J (1994) 2.55
Impact of polymer tether length on multiple ligand-receptor bond formation. Science (2001) 2.49
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res (2005) 2.34
Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging (2004) 2.19
Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials (2006) 1.94
Targeted imaging using ultrasound. J Magn Reson Imaging (2002) 1.88
Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr (2002) 1.85
A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 1.79
Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 1.77
Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol (2007) 1.70
Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release (2005) 1.68
Lateral phase separation in lipid-coated microbubbles. Langmuir (2006) 1.52
Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 1.51
Targeted imaging using ultrasound contrast agents. Progess and opportunities for clinical and research applications. IEEE Eng Med Biol Mag (2004) 1.46
Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy. Mol Imaging (2006) 1.43
Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging (2008) 1.34
Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol (2007) 1.31
Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials (2005) 1.25
Ultrasound radiation force modulates ligand availability on targeted contrast agents. Mol Imaging (2006) 1.23
The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol (2004) 1.00
Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials (1988) 0.94
In vitro blood reactivity to hydroxylated and non-hydroxylated polymer surfaces. Biomaterials (2007) 0.92
In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimmun (2005) 0.90
Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. Exp Cell Res (1996) 0.88
Intravenous myocardial contrast echocardiography for the diagnosis of coronary artery disease. Curr Opin Cardiol (2005) 0.82
The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol (2000) 0.82
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
The chemistry of two-dimensional layered transition metal dichalcogenide nanosheets. Nat Chem (2013) 4.57
A microenvironmental model of carcinogenesis. Nat Rev Cancer (2008) 4.40
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol (2006) 3.98
Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res (2006) 3.90
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med (2008) 3.48
Single-layer MoS2 phototransistors. ACS Nano (2011) 3.43
Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res (2009) 3.40
LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell (2009) 3.34
Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China. Diabetes Care (2013) 2.89
Graphene-based composites. Chem Soc Rev (2011) 2.85
Growth of large-area and highly crystalline MoS2 thin layers on insulating substrates. Nano Lett (2012) 2.81
Adaptive therapy. Cancer Res (2009) 2.81
Radiomics: the process and the challenges. Magn Reson Imaging (2012) 2.65
Acidity generated by the tumor microenvironment drives local invasion. Cancer Res (2013) 2.63
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. Nat Med (2011) 2.49
The evolution of dip-pen nanolithography. Angew Chem Int Ed Engl (2004) 2.49
Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics (2007) 2.46
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol (2012) 2.45
The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med (2008) 2.43
Calibrating the end-Permian mass extinction. Science (2011) 2.41
The magnitude of radiation force on ultrasound contrast agents. J Acoust Soc Am (2002) 2.38
Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol (2009) 2.27
Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc Natl Acad Sci U S A (2010) 2.20
Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging (2004) 2.19
Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia (2005) 2.17
The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. Pharmacogenet Genomics (2014) 2.15
Polymer pen lithography. Science (2008) 2.14
Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J Acoust Soc Am (2007) 2.11
Tumor pH and its measurement. J Nucl Med (2010) 2.08
Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med (2003) 2.05
Chloride intracellular channel-4 is a determinant of native collateral formation in skeletal muscle and brain. Circ Res (2009) 2.02
Electrically conductive and optically active porous silicon nanowires. Nano Lett (2009) 2.00
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1. Nat Chem Biol (2009) 2.00
Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol (2009) 1.98
High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med (2006) 1.97
Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol (2007) 1.94
The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res (2009) 1.92
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol (2004) 1.92
Acoustic response of compliable microvessels containing ultrasound contrast agents. Phys Med Biol (2006) 1.91
Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol (2007) 1.90
Targeted imaging using ultrasound. J Magn Reson Imaging (2002) 1.88
Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology (2007) 1.86
Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature (2005) 1.86
Hitting multiple targets with multimeric ligands. Expert Opin Ther Targets (2004) 1.86
Graphene-based materials: synthesis, characterization, properties, and applications. Small (2011) 1.85
G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. J Neurosci (2005) 1.84
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J (2007) 1.84
Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res (2009) 1.84
A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 1.79
Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology (2009) 1.78
Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction. IEEE Trans Ultrason Ferroelectr Freq Control (2005) 1.77
Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides. Bioorg Med Chem (2008) 1.75
Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol (2006) 1.75
On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging. Lab Chip (2007) 1.74
Draft genome of the kiwifruit Actinidia chinensis. Nat Commun (2013) 1.72
Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release (2006) 1.70
3D graphene-cobalt oxide electrode for high-performance supercapacitor and enzymeless glucose detection. ACS Nano (2012) 1.70
Fabrication of single- and multilayer MoS2 film-based field-effect transistors for sensing NO at room temperature. Small (2011) 1.69
Congenic fine-mapping identifies a major causal locus for variation in the native collateral circulation and ischemic injury in brain and lower extremity. Circ Res (2013) 1.68
Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release (2005) 1.68
Imaging pH and metastasis. NMR Biomed (2011) 1.67
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A (2013) 1.66
Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions. Anal Biochem (2004) 1.66
Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol (2011) 1.64
Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia (2003) 1.63
Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies. Mol Imaging (2010) 1.63
Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol (2013) 1.62
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology (2014) 1.62
Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl Med Biol (2007) 1.60
Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir (2011) 1.60
Single-layer semiconducting nanosheets: high-yield preparation and device fabrication. Angew Chem Int Ed Engl (2011) 1.60
Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J Control Release (2009) 1.60
Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol (2006) 1.59
Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH. Bioorg Med Chem Lett (2004) 1.58
Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol (2003) 1.57
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes. JACC Cardiovasc Interv (2009) 1.56
A mechanism related to the yeast transcriptional regulator Paf1c is required for expression of the Arabidopsis FLC/MAF MADS box gene family. Plant Cell (2004) 1.55
Tailoring the size distribution of ultrasound contrast agents: possible method for improving sensitivity in molecular imaging. Mol Imaging (2007) 1.55
The VERNALIZATION INDEPENDENCE 4 gene encodes a novel regulator of FLOWERING LOCUS C. Plant J (2002) 1.55
Quantitative imaging in cancer evolution and ecology. Radiology (2013) 1.55
Quantitative volumetric perfusion mapping of the microvasculature using contrast ultrasound. Invest Radiol (2010) 1.54
Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther (2005) 1.54
Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia (2005) 1.54
Lateral phase separation in lipid-coated microbubbles. Langmuir (2006) 1.52
Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Clin Gastroenterol Hepatol (2013) 1.51
Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol (2010) 1.51
Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation. FASEB J (2011) 1.50
Of cancer and cave fish. Nat Rev Cancer (2011) 1.50